While President Donald Trump's White House has hinted at new opportunities for states to develop new approaches to their Medicaid prescription drug programs, other states have already begun taking steps on their own.
State officials during a National Academy for State Health Policy pointed to a set […]

Truven Health in an opinion brief shared the payer perspective on outcomes-based contracts (OBCs), and offered some insights as to what steps the industry can take to make them "meaningful, sustainable and scalable."
According to the brief, payer executives interviewed mostly said they were […]

Amazon has reportedly started selling private-label over-the-counter medicines and health care items, CNBC reported Tuesday.
Amazon began selling the line of medications called Basic Care in August. The line includes some 60 items produced by Perrigo exclusively for the tech giant.
According to a […]

Nanalyze in a report gave a brief summary of six startups looking to deliver health care management technology using artificial intelligence (AI).
Below are a few of those companies:
Prognos
New York-based Prognos has developed roughly 1,000 algorithms to catch disease as early as possible to […]

Are you searching for that opportunity to help propel you to the next promotion? Add to your credentials so you stay relevant? Give you the tools to affect change in healthcare in a new way?
If so, you may be interested in the well-respected online MS+MBA and Certificate Programs in Applied […]

Below is an excerpt from the full statement U.S. Food and Drug Administration Commissioner Scott Gottlieb gave in response to the administration's request for new FDA funding:
"New scientific opportunities, as well as advances in manufacturing and commerce, give the U.S. Food and Drug […]

New data from the Centers for Medicare and Medicaid Services (CMS) Office of the Actuary published in Health Affairs suggests health care will make up 19.7 percent of the U.S. economy by 2026.
According to researchers, spending on hospital care could see an average growth rate of 5.5 percent […]

The Institute for Clinical and Economic Review on Wednesday released a Final Evidence Report and Report-at-a-Glance on voretigene neparvovec (VN; Luxturna, Spark Therapeutics) for treatment of vision loss associated with RPE65-mediated retinal disease. Approved in 2017, VN is the first treatment for […]

Some experts have expressed some skepticism about President Donald Trump's administration's plans to reduce drug prices, Fierce Healthcare reports.
The concerns were spurred by the White House Council of Economic Adviser's 30-page white paper released Feb. 9, which outlines a number of policy […]

The Food and Drug Administration reportedly threw its support behind President Donald Trump's budget proposal.
To read the full report on The Pharma Letter, click here. (Paid subscription required) […]

In a column published Feb. 14 in STAT, National Pharmaceutical Council Chief Science Officer and Vice President Robert Dubois discusses the risk of misinterpreting health care spending statistics.
Dubois in his write up says people are more often to panic over remote risks, but shrug at dangers […]

Access HealthNet Co-Founder, Chairman and CEO Eric Haberichter recently talked with Relentless Health Value about a range of topics, including value-based and fee-for-service payment models, as well as price transparency.
Haberichter brings more than 25 years of experience in the health industry to […]

A recent feature in Value and Outcomes Spotlight, a publication by the International Society for Pharmacoeconomics and Outcomes Research, delves into how the health industry is undertaking value assessments for cancer immunotherapies.
Christiane Truelove in her write up discusses how European […]

The Institute for Clinical and Economic Review (ICER) says upcoming reports will focus on the comparative clinical effectiveness and value of high-risk prostate cancer and hereditary amyloidosis treatments.
According to a press release, the reports will be reviewed during the September meeting of […]

The National Committee for Quality Assurance (NCQA) recently announced it is looking for the public's input on new Healthcare Effectiveness Data and Information Set (HEDIS) measures.
"This is an opportunity for health plans, purchasers, consumers and other stakeholders to weigh in on the relevance, […]

A report by Centers for Medicare and Medicaid Services actuaries published Wednesday in Health Affairs projects drug spending will see the fastest growth rate among other health care goods and services categories.
Overall, the actuaries forecast a 5.5 percent annual growth rate in health care […]

The abstract submission deadline for the International Society for Pharmacoeconomics and Outcomes Research's 8th Asia Pacific Conference is rapidly approaching.
Interested parties have until March 14 to submit their research abstracts for consideration.
According to a press release from ISPOR, […]

The Institute for Clinical and Economic Review (ICER) on Thursday released an Evidence Report assessing the comparative clinical effectiveness and value of tisagenlecleucel (Kymriah, Novartis) and axicabtagene ciloleucel (Yescarta, Kite Pharma/Gilead).
The report found that both therapies provided […]

The use of artificial intelligence (AI) in the health care industry has posted significant growth, and expectations suggest that movement won't lose steam any time soon.
According to a report published Monday by Verdict, the number of companies bringing AI into health care has risen to 100 in 2017 […]

A bill recently introduced in the U.S. legislature could prove beneficial to a growing market for high-deductible health plans (HDHPs).
The legislation, titled "The Chronic Disease Management Act of 2018," would allow the health plans to deliver chronic disease prevention services to patients […]

A recent survey released by Haymarket Medical Education found U.S. clinicians are by and large unprepared for some requirements set forth by the Quality Payment Program (QPP).
The QPP was created through the Medicare Access and CHIP Reauthorization Act of 2015. The program aims to offer Medicare […]

Outcome Health and the American College of Cardiology (ACC) on Monday announced a partnership aimed at improving heart health in the U.S.
The partnership, according to a press release, is a collaborative effort between Outcome Health and ACC's CardioSmart, a "patient education and empowerment […]

Tech giant Amazon is continuing its push into the health care industry, now looking to develop itself into a major supplier for hospitals and outpatient clinics across the U.S.
The Wall Street Journal on Tuesday published the report on Amazon's latest pursuit.
According to a Healthcare Dive […]

A White House council on Friday outlined in a white paper its recommendations to bring down drug prices.
The Council of Economic Advisers (CEA), according to a Modern Healthcare report, proposed easing some government regulations to rein in high drug costs.
Backing the U.S. Food and Drug […]

The International Society for Pharmacoeconomics and Outcomes Research has published its "Top 10 Trends in Health Economics and Outcomes Research" rundown for 2018.
According to a press release, the list "reflects the top trends that key ISPOR members indicate will have the most influence in the […]

Medical Science Liaison (MSL) personnel play an ever crucial and widening role in communicating the value and science of increasingly complex therapies to opinion leaders and stakeholder groups.
The challenge for senior management is to ensure their MSL teams are optimally provided for in terms of […]

Evidera Market Access Consulting Vice President and General Manager Cheryl Ball takes a look at much-anticipated presidential action on U.S. drug pricing in her report published in The Evidera Forum.
Ball details how value-based arrangements have evolved over time in an ever-changing health care […]

McKesson recently released its quarterly earnings for the fourth calendar quarter of 2017. Learn more on the three interrelated mix changes that challenge wholesalers' profits from the growth of specialty pharmacy drugs. (Source: Drug Channels, 2/6/18) […]

The FDA is continuing to make progress towards precision health care. According to a new report from the Personalized Medicine Coalition (PMC), more than 1 in 4 drugs approved over the past 4 years have been a personalized medicine. Find out more here. (Source: Laurie Toich, Specialty Pharmacy […]

Value-based care initiatives and ideas have really been growing over the past few years, with outcome-based arrangements being one of the newest ideas. Could this be the year it all takes off? Find out more here. (Source: Matthew Fisher, HiMSS, Linkedin) […]

About

Stay Connected

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.